GE HealthCare Technologies (GEHC) shares soared 10.6% in the last trading session to close at $64.98. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 31.4% loss over the past four weeks.The upside can be attributed to relief-rally across global markets following the announcement of a 90-day pause on tariff hike by the United States.This medical technology company is expected to post quarterly earnings of $0.91 per share in its up ...

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!Shares of GE HealthCare (NASDAQ: GEHC ) have been a publicly traded entity since early 2023, when the healthcare business was spun off from GE. A $60 stock at the time, has largely traded in a $60 ...

Shares in GE HealthCare Technologies (GEHC -10.04%) were down 9.5% at 1 p.m. today. The decline follows the U.S.'s wide-scale implementation of tariffs. GE HealthCare is a truly global company, and the tariff actions will negatively impact its business.GE HealthCare and tariffsThe company generated about $9 billion in revenue from North America in 2024, and $10.7 billion from the rest of the world (including $2.4 billion from China). It's a global company, competing with leading healthcare equipment compani ...

GE HealthCare Technologies Inc. (GEHC) , yesterday, announced the completion of its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd ("NMP") from Sumitomo Chemical, giving it full ownership. The intent to acquire the remaining 50% stake in NMP was announced in December 2024. GE HealthCare acquired Amersham plc in 2004 and subsequently held a 50% stake in NMP. As part of GE HealthCare, NMP is expected to play a key role in bringing its deep expertise and scale to global innovators lookin ...

GE HealthCare Technologies Inc. (GEHC) recently unveiled Revolution Vibe, an advanced computed tomography (CT) system featuring Unlimited One-Beat Cardiac imaging designed to produce high-quality, consistent images even in complex cases such as atrial fibrillation. Integrated with cutting-edge technologies, Revolution Vibe enhances diagnostic speed and accuracy while improving patient comfort and optimizing workflow efficiency. As medical institutions continue to seek advanced imaging solutions that balance ...

GEHC further stated that the FDA approved Flyrcado for patients with known or suspected CAD in 2024. This is expected to deliver higher diagnostic efficacy, unlike SPECT MPI, the predominant procedure used in nuclear cardiology at present. GE HealthCare's management believes that the launch of Flyrcado represents a significant advancement in cardiac care, providing a new, highly effective diagnostic tool for those with known or suspected CAD. Additionally, Flyrcado has been granted traditional pass-through ...

Company Overview - GE HealthCare Technologies Inc. (GEHC) has launched the Invenia Automated Breast Ultrasound (ABUS) Premium, a 3D ultrasound product featuring advanced AI capabilities aimed at improving screening for patients with dense breasts [1][2] - The Invenia ABUS Premium has received FDA premarket approval and is set to be launched in key markets by 2025 [1] Product Significance - Approximately 71% of breast cancers occur in dense breast tissue, with studies indicating that 40% of women and 70% of Asian women have dense breasts, increasing their cancer diagnosis risk [5] - The Invenia ABUS Premium's AI features enhance clinical workflow by reducing scanning time and improving detection of small, early-stage cancers [6][7] Market Potential - The global breast cancer diagnostics market was valued at $4.3 billion in 2022 and is projected to grow at a CAGR of 7.4% from 2023 to 2030, driven by technological advancements and rising breast cancer prevalence [8] Financial Performance - GE HealthCare has a market capitalization of $37.27 billion and an earnings yield of 5.8%, significantly higher than the industry average of 0.3% [4] - The company reported an earnings surprise of 15.1% in the last quarter [4] Stock Performance - Following the product announcement, GEHC shares declined by nearly 1.1%, despite historical trends showing that product innovations typically boost top-line growth [3] - Over the past year, GEHC shares have decreased by 6.6%, contrasting with a 9.9% rise in the industry and a 9.1% gain in the S&P 500 [10]

GE HealthCare Technologies, Inc. (GEHC) is well-poised for growth in the coming quarters, courtesy of its continued focus on innovations. The optimism, led by strong fourth-quarter 2024 performance and acquisitions, is expected to contribute further. However, geopolitical tensions and stiff competition are concerning.This Zacks Rank #3 (Hold) company’s shares have lost 11.6% in the past six months against the 1.2% growth of the industry. The S&P 500 composite has lost 0.9% during the said time frame.The ren ...

Last week, U.S. President Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on those from China to 20%.China responded to Trump’s recent tariff hikes by placing its own tariffs on certain U.S. goods, sanctioning American companies, and planning to file a complaint with the World Trade Organization.China also banned imports of genetic sequencers from Illumina Inc ILMN.Also Read: Why Is GE HealthCare Stock Trading Soaring On Thursday?Goldman Sachs has gro ...

GE HealthCare Technologies Inc. (GEHC) has recently unveiled the Genesis portfolio, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions designed to modernize healthcare data management. Genesis is likely to offer scalable, secure, and interoperable solutions that help hospitals and health systems streamline workflows, enhance patient data access, and reduce operational costs.As healthcare organizations face increasing data complexity and IT challenges, Genesis provides a flexible ...